Cite
HARVARD Citation
Baksmeier, C. et al. (2021). Modified recombinant human IgG1‐Fc is superior to natural intravenous immunoglobulin at inhibiting immune‐mediated demyelination. Immunology. 164 (1), pp. 90-105. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Baksmeier, C. et al. (2021). Modified recombinant human IgG1‐Fc is superior to natural intravenous immunoglobulin at inhibiting immune‐mediated demyelination. Immunology. 164 (1), pp. 90-105. [Online].